Medigus: Polyrizon Innovative Technology Demonstrated it may Prevent Allergic Reaction Caused by Common Allergens – Yahoo Finance

Polyrizon tested its Capture and Contain (C&C™) proprietary hydrogel technology against house dust mite allergen and Timothy grass pollen allergen in cell culture assays
Tel Aviv, Israel, Nov. 01, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd. (35.86%), informed Medigus that its pre-clinical data demonstrated a potential to prevent allergic reaction induced by house dust mites (HDM) and Timothy grass pollen allergens and may also prevent respiratory tract allergy reactions caused by other allergens.
Data from Polyrizon’s cell-culture study, demonstrates that its Capture and Contain (C&C™) innovative product, PL-14, has the potential to reduce the inflammatory response while challenging the host cells with group 1 allergens from Dermatophagoides pteronyssinus (Der p1) and pollen major allergen (PhlP1) from Timothy grass, which is a common perennial grass native to most of Europe. House dust mites are microscopic, insect-like pests that generate some of the most common indoor substances—or allergens—that can trigger allergic reactions such as rhinitis, asthma and atopic dermatitis, expressed with running nose, itchy eyes, and skin itching in many people.
Grass pollen allergy is one of the most common allergies worldwide and can trigger of allergic rhinitis (hay fever) and asthma symptoms. Pollen seasons can last for several months and exposure is difficult to avoid.
Polyrizon tested a few prototypes of its C&C platform as a shield against Der p1 and PhlP1 allergens. In these studies, the lead product candidate, PL14, prevents the interaction of the allergen with the host cell, as expressed with reduced secretion of the chemokine cytokine IL-8, an important inducer of allergic reactions.
Polyrizon’s lead product candidate, PL-14, has been designed to protect the nasal cavity and the respiratory tract creating an innate immune response by creating a physical barrier. This barrier may prevent allergens from reaching the upper respiratory epithelial cells and may decrease the inflammatory response that leads to allergic reactions.
Recent pre-clinical studies by Polyrizon demonstrated the impact of the C&C product line that was capable to provide a barrier against allergens and a variety of different respiratory viruses such as cold, flu and COVID-19.
The first efficacy results are expected within the next 12 months.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus' affiliations in the medical solutions arena include ownership in ScoutCam Inc. and Polyzion Ltd. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeff's Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Medigus uses forward-looking statements in this press release when it describes the medical potential of the PL-14. Because such statements deal with future events and are based on Medigus’ current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Medigus could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the Securities and Exchange Commission (“SEC”). Except as otherwise required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Medigus is not responsible for the contents of third-party websites.
Company Contact:
Tali Dinar
Chief Financial Officer
+972-8-6466-880
[email protected]
Investor Relations Contact:
Miri Segal
CEO
MS-IR LLC
+1-917-607-8654
[email protected]

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven…
Inflation is high. You might as well profit from it.
What was it about Desktop Metal today that got everyone so excited about 3D printing stocks again? In a press release today, Desktop Metal announced the opening of a new facility "to meet demand for the world's fastest metal 3D printing technology." "We are experiencing growing, pent-up demand for our Production System P-50 solution," explained Desktop Metal CEO Ric Fulop.
This year has been a bumpy ride for Ocugen (OCGN) investors, yet rewarding for those who were able to stomach the volatility. While shares have almost doubled over the past month, the year-to-date performance shows a 664% share haul. Ocugen’s success has been based on its seemingly improbable transformation from a company focused on eye diseases to one chasing the opportunities presented by Covid-19; the biotech holds the US rights for Covaxin, a Covid-19 vaccine candidate developed by India-bas
Hydrogen fuel cell stocks rocketed on Monday alongside investor interest in clean energy stocks as the two-week COP26 climate summit got underway in Glasgow, Scotland, and President Joe Biden's reconciliation infrastructure bill inches closer to passing. Bloom Energy (NYSE: BE): Up 3.5%. Fuel cell stocks have been red-hot in recent days, with each of the three stocks blasting double-digits higher in the month of October.
In this article, we will take a look at the 10 best basic material stocks to buy now. You can skip our detailed analysis of these companies and go directly to the 5 Best Basic Material Stocks to Buy Now. Over the last few decades, rising demand for raw materials to support infrastructure development, industrialization, and […]
(Bloomberg) — BP Plc said it would buy back an additional $1.25 billion of shares, using the proceeds of surging energy prices to woo investors who have become disenchanted with oil and gas. Most Read from BloombergInto the Metaverse: Where Crypto, Gaming and Capitalism CollideSupply Chain Crisis Risks Taking the Global Economy Down With ItAtlanta’s Crowded Election Pits Former Mayor Versus ‘Anyone But’Can a New Mayor Fix Seattle’s Downtown?In Minneapolis Election, the Future of Policing Is at
Shares of Zillow Group Inc. took a dive Monday, after KeyBanc analyst Edward Yruma highlighted how most of the homes the real estate services company purchased, with an aim to flip them, were now worth less than what they paid for them.
The stock markets are at or near record highs right now, buoyed by a strong investors sentiment, especially among retail investors. Stocks represent a strong return while interest rates and bond yields remain low. But for return-minded investors, stocks are not the only game in town. The notoriously volatile Bitcoin has surged 109% this year, peaking above $65,000 earlier this month. Yet, some crypto watchers believe the digital coin will climb even higher. The cryptocurrency sector is worth app
Top news and what to watch in the markets on Tuesday, November 2, 2021.
Biotech stocks appear to be poised for a strong showing in November for a host of reasons. Second, the latest earnings reports from top big pharma companies like Merck have been better than expected so far. Lastly, scores of drugmakers are slated to release key clinical and regulatory updates this month.
Zillow Offers aims to sell 7,000 homes for $2.8 billion, Bloomberg reported Monday, citing people familiar with the matter.
(Bloomberg) — China’s transformation from a financial-technology backwater into a $46 trillion-a-year global leader in digital payments left most international investors watching in awe from the sidelines. Now India is undergoing its own fintech revolution, and the race is on to grab a piece of the action.Most Read from BloombergInto the Metaverse: Where Crypto, Gaming and Capitalism CollideSupply Chain Crisis Risks Taking the Global Economy Down With ItAtlanta’s Crowded Election Pits Former Ma
Ford Motor Company (NYSE: F) shares have outperformed the S&P 500 in 2021, generating a year-to-date total return of 97.8%. But after nearly doubling in share price this year, investors may be wondering if there’s any value left in Ford stock. Earnings: A price-to-earnings ratio (PE) is one of the most basic fundamental metrics for gauging a stock’s value. The lower the PE, the higher the value. For comparison, the S&P 500’s PE is at about 29, nearly double its long-term average of 15.9. Ford’s
(Bloomberg) — Tesla Inc.’s latest rally has blasted co-founder Elon Musk’s wealth past a new milestone: It now eclipses famed investor Warren Buffett’s fortune by a factor of three. Most Read from BloombergInto the Metaverse: Where Crypto, Gaming and Capitalism CollideSupply Chain Crisis Risks Taking the Global Economy Down With ItAtlanta’s Crowded Election Pits Former Mayor Versus ‘Anyone But’Can a New Mayor Fix Seattle’s Downtown?In Minneapolis Election, the Future of Policing Is at StakeMusk
In this article, we discuss the 10 best shipping and container stocks to buy. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Shipping and Container Stocks To Buy. According to a recent World Trade Organization estimate, global merchandise trade volume is expected to grow by 10.8% in […]
Nio Inc (NYSE: NIO) shares are trading higher, reversing following earlier weakness. The stock initially dipped after the company reported a 27.5% year-over-year dip in October vehicle deliveries. Shares of several companies in the clean energy space are also trading higher as investors weigh US President Biden's speech at the COP26 climate summit, in which he addressed climate change goals. Strength could also be attributed to US infrastructure optimism, Tesla, Inc. (NASDAQ: TSLA) hitting a new
(Bloomberg) — Iron ore futures extended losses below $100 a ton on shrinking steel output in China and signs economic growth is facing mounting headwinds.Most Read from BloombergInto the Metaverse: Where Crypto, Gaming and Capitalism CollideSupply Chain Crisis Risks Taking the Global Economy Down With ItAtlanta’s Crowded Election Pits Former Mayor Versus ‘Anyone But’Can a New Mayor Fix Seattle’s Downtown?In Minneapolis Election, the Future of Policing Is at StakePrices in Singapore slumped for
Professional investors tend to dump some of their losers by the end of October, creating greater value in some stocks.
The stock's momentum from last week is continuing as the company prepares to report its third-quarter update.

source